MESIANO, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 256
NA - Nord America 85
AS - Asia 19
AF - Africa 3
Totale 363
Nazione #
IT - Italia 131
US - Stati Uniti d'America 85
BE - Belgio 77
CH - Svizzera 20
DE - Germania 13
CN - Cina 9
IE - Irlanda 5
FR - Francia 4
CI - Costa d'Avorio 3
TW - Taiwan 3
BY - Bielorussia 2
GB - Regno Unito 2
IR - Iran 2
TH - Thailandia 2
AT - Austria 1
FI - Finlandia 1
JO - Giordania 1
SG - Singapore 1
VN - Vietnam 1
Totale 363
Città #
Brussels 77
Turin 68
Council Bluffs 27
Ashburn 20
Bern 20
New York 15
Boardman 7
Miami 7
Beijing 6
Dublin 5
Nuremberg 4
Abidjan 3
Brescia 3
Cormeilles-en-Parisis 3
Luni 3
Palermo 3
Rome 3
Shanghai 3
Taipei 3
Bangkok 2
Bari 2
Bonn 2
Collegno 2
Cortona 2
Genoa 2
Milan 2
Milwaukee 2
Minsk 2
Pont-Canavese 2
Ponteranica 2
Seattle 2
Venice 2
Arezzo 1
Bergamo 1
Berlin 1
Carrickfergus 1
Chicago 1
Falconara Marittima 1
Fossano 1
Frosinone 1
Hanoi 1
Lappeenranta 1
London 1
Mongrando 1
Montefalco 1
Padova 1
Paris 1
Vienna 1
Washington 1
Totale 323
Nome #
Effective combination of biocompatible zinc oxide nanocrystals and high-energy shock waves for the treatment of colorectal cancer 62
Artificial and Naturally Derived Phospholipidic Bilayers as Smart Coatings of Solid-State Nanoparticles: Current Works and Perspectives in Cancer Therapy 52
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes 35
Anti-CD38 targeted nanotrojan horses stimulated by acoustic waves as therapeutic nanotools selectively against Burkitt’s lymphoma cells 26
CSPG4 as innovative target for CAR redirected CIK lymphocytes against soft tissue sarcomas 25
Cytokine-induced killer cells kill chemo-surviving melanoma cancer stem cells 25
Anti-CSPG4 CAR.CIK lymphocytes are effective against advanced sarcomas in 3D spheroid and xenograft models 23
Cytokine-Induced Killer (CIK) Cells, In Vitro Expanded under Good Manufacturing Process (GMP) Conditions, Remain Stable over Time after Cryopreservation 21
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy 19
EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma 15
Explorative model of imatinib resistant wild type GIST and potential immunotherapy strategies 14
Adoptive immunotherapy against sarcomas 13
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas 13
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells 13
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells 12
Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer 12
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST 12
Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity 11
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors 11
Correction to: Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity 9
Totale 423
Categoria #
all - tutte 2.388
article - articoli 2.388
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.776


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023236 0 0 0 0 0 17 8 144 10 26 3 28
2023/2024187 3 35 14 17 9 41 17 23 17 11 0 0
Totale 423